Extracellular and intracellular bactericidal activities of XF-70 against small-colony variant hemB mutants of meticillin-susceptible and meticillin-resistant Staphylococcus aureus

This publication has 13 references indexed in Scilit:

• Investigation of the Potential for Mutational Resistance to XF-73, Retapamulin, Mupirocin, Fusidic Acid, Daptomycin, and Vancomycin in Methicillin-Resistant Staphylococcus aureus Isolates during a 55-Passage Study
  Antimicrobial Agents and Chemotherapy, 2011
• XF drugs: A new family of antibacterials
  Drug News & Perspectives, 2010
• XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms
  Journal of Antimicrobial Chemotherapy, 2009
• XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity
  Journal of Antimicrobial Chemotherapy, 2009
• Inactivation of a subpopulation of human neutrophils by exposure to ultrahigh-molecular-weight polyethylene wear debris
  FEMS Immunology & Medical Microbiology, 2007
• Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections
  Nature Reviews Microbiology, 2006
• Increased Expression of Clumping Factor and Fibronectin-Binding Proteins by hemB Mutants of Staphylococcus aureus Expressing Small Colony Variant Phenotypes
  Infection and Immunity, 2002
• Recovery of Small Colony Variants ofStaphylococcus aureusFollowing Gentamicin Bead Placement for Osteomyelitis
  Clinical Infectious Diseases, 1997
• A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly
  Journal of Bacteriology, 1997
• Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes
  Antimicrobial Agents and Chemotherapy, 1979